4//SEC Filing
Lofton Kevin E 4
Accession 0001127602-23-014554
CIK 0000882095other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:57 PM ET
Size
7.2 KB
Accession
0001127602-23-014554
Insider Transaction Report
Form 4
Lofton Kevin E
Director
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2023-05-03$79.45/sh+10,173$808,245→ 10,173 totalExercise: $79.45Exp: 2033-05-03→ Common Stock (10,173 underlying) - Award
Common Stock
2023-05-03+1,887→ 92,653 total(indirect: By Trust)
Footnotes (3)
- [F1]Represents 1,887 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023.
- [F2]Shares are held in a Revocable Living Trust.
- [F3]100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001468818
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 5:57 PM ET
- Size
- 7.2 KB